Practitioner-Led Care Organizations

Care delivery organization offering telehealth or hybrid psychedelic-adjacent clinical services.

Care delivery organization providing specialty or outpatient psychedelic-adjacent clinical services.

Advanced Integrative Medical Science (AIMS) Institute is a Seattle-based clinic led by Dr. Sunil Aggarwal offering ketamine-assisted psychotherapy, entheogen-assisted therapy, integrative oncology, and palliative care. The institute is notable for a landmark DEA lawsuit seeking right-to-try psilocybin access for patients with serious illness, placing it at the forefront of psychedelic medicine advocacy and clinical practice in the US.

US-based philosopher, researcher, and psychedelic integration guide with a Master's degree in philosophy focused on the nature of healing in the psychedelic experience, who has worked as a research assistant at a ketamine clinic and written curriculum for multiple psychedelic therapy certificate programs. Criddle offers a Philosophy and Psychedelics online course and integration coaching, has contributed to Blossom Analysis and Psychedelic Science Review, and co-produced the documentary EntheoMagus exploring the psychedelic origins of Mormonism and the role of entheogens in American occultism.

The American Psychiatric Association is the national medical specialty society for psychiatry in the United States, with headquarters in Washington, DC and a membership base of psychiatric physicians. It serves psychiatrists and the broader mental health field through official position statements, clinical guidance, journals, and public policy communications. Its core activity is to represent psychiatry in clinical, professional, and policy discussions affecting mental health care. APA has an explicit, cautious stance on psychedelics and empathogens in mental health care. Its 2022 position statement says there is not yet adequate scientific evidence to endorse use outside approved investigational studies, while supporting continued research under strong scientific and regulatory standards. In 2024 APA also submitted comments to FDA on MDMA and in 2026 it publicly welcomed federal investment in psychedelic research while reiterating the need for controlled studies and patient protections.

Apollo Neuroscience is a US company founded by Dr. David Rabin MD PhD that makes the Apollo Neuro wearable device, which delivers gentle vibrations to modulate the autonomic nervous system, reducing stress and improving sleep and recovery. The company is conducting IRB-approved clinical trials in partnership with MAPS evaluating the device's ability to sustain remission from PTSD following MDMA-assisted therapy, and has published research showing it reduces anxiety and improves integration outcomes in psychedelic-assisted sessions.

APSTA, the Association for Psychedelic Science and Therapy Austria, is based in Vienna and describes itself as Austria's leading network for experts in psychedelic research and therapy. It serves medical, psychotherapeutic, psychological, and other professional audiences, with a stated focus on connecting professionals and sharing knowledge, best practices, and experience. Its core activities center on networking, setting guidelines and standards, and education and outreach. APSTA presents itself as a professional association focused on safe, responsible, and evidence-based use of psychedelic substances in therapy and research. Its role appears primarily educational and field-building rather than legislative, with emphasis on ethical practice, public information, and interdisciplinary exchange. Documented examples on its site include supporting research projects, promoting standards for therapy and research, and informing the public about opportunities and risks of psychedelic therapies.

ATMA Journey Centers is an Alberta-based Canadian pioneer in psychedelic-assisted therapy, operating clinically supervised locations across Canada while offering comprehensive psychedelic-assisted therapy training programs (ATMA CENA) covering psilocybin, MDMA, and ketamine for healthcare professionals. With 740+ training alumni and 800+ community members, ATMA also operates a clinic network partnership program and Phase II psilocybin clinical trials with Health Canada approval.

Being True to You (BTTY) is a pioneering Denver-based psychedelic integration and addiction recovery coaching company founded in 2010 by Deanne Adamson, operating the first and most comprehensive Transformational & Integration Coach Training Program with over 500 certified coaches worldwide. The organization offers one-on-one integration coaching, 12-month coach certification, and sitter and retreat staff training, partnering with wellness retreats, ibogaine programs, and psychedelic providers globally.

Breakthrough Therapies is a Toronto-based ketamine-assisted psychotherapy clinic and training organization founded by Dr. Dawn DeCunha, offering certified KAP training programs (Level 1 and Level 2 mentoring practicum) alongside a clinical KAP retreat program at their Aspenwood location north of Toronto. The organization bridges Trauma Informed and Psychedelically Informed Practice, training clinicians in psychedelic psychotherapy principles while providing patient care.

Ibogaine preparation, integration, and aftercare coaching platform founded in 2009 by Jonathan Dickinson, former Director of the Global Ibogaine Therapy Alliance. Ceiba provides personalized one-on-one coaching across all phases of the ibogaine experience, grounded in harm reduction, neurodiversity, and spiritual emergence perspectives, and offers a free weekly recovery group for ibogaine treatment alumni.

Care delivery organization providing specialty or outpatient psychedelic-adjacent clinical services.

Calgary-based psychedelic integration therapy practice founded by Charmaine Husum DKATI, RTC, CT, an internationally recognized registered Canadian art therapist and somatic practitioner specializing in ayahuasca, entheogenic, and plant medicine preparation and integration. Drawing on somatic art therapy, Kundalini meditation, dreamwork, and sacred geometry, Centre of the Heart supports trauma recovery and psychological healing, and Husum's forthcoming book Psychedelics & Art Therapy: A Trauma-Informed Manual for Somatic Self-Discovery (Routledge, 2025) is the first of its kind.

Care delivery organization offering telehealth or hybrid psychedelic-adjacent clinical services.

Care delivery organization offering telehealth or hybrid psychedelic-adjacent clinical services.

Door of Perception is the practice of Dorien, a Netherlands-based psychedelic guide, coach, and medical anthropologist who co-founded the OPEN Foundation in 2007 and brings over 20 years of experience in harm reduction at festivals such as Kosmicare, Zendo, and Psycare. She offers online courses for safe DIY psychedelic journeys, one-on-one psilocybin truffle sessions in Amsterdam, and training workshops for guides and mental health professionals.

Enovex Pharmacy is a Los Angeles-area compounding pharmacy specializing in ketamine formulations including troches, sublingual tablets, and nasal spray for therapeutic clinic and at-home use. The pharmacy has supplied ketamine products to telehealth providers including Mindbloom for at-home ketamine-assisted therapy programs.

Nonprofit organization operating the Psychedelic Peer Support Line, providing phone and text support during and after psychedelic experiences with escalation to emergency services where needed.

TAIP is an Estonian organization advancing science-based approaches to the use of psychedelics in contemporary therapeutic practices.

The Deutsche Gesellschaft für Psychedelische Forschung und Therapie e.V. is a German professional association based in Germany for physicians, psychologists, and other professionals working in psychedelic research and therapy. Its official site describes it as a specialist society that offers information exchange, supports standards and guidelines, and provides expert advice to professional and policy bodies. Membership is intended for professional practitioners rather than the general public. Its field role is centered on the scientific and clinical introduction of psychedelic-assisted therapies in Germany, with explicit attention to evidence, quality assurance, training, and public communication. The organization also says it supports patient- and family-oriented exchange, advises on certification and approval processes, and helps shape structural conditions for possible clinical use. Current site content highlights a 2026 case under Germany's compassionate-use program for psilocybin in depression, an online members' meeting, and planned contributions to the DGPPN congress.

Guides Collective is a private community and concierge matching service connecting individuals seeking psychedelic-assisted healing with a vetted network of 600+ practitioners across the US and Canada. All guides undergo in-depth screening, background checks, and must have at least two years of professional experience. The organization also provides business education, marketing support, mentorship programs, and peer community resources to help guides build sustainable practices.

Care delivery organization offering telehealth or hybrid psychedelic-adjacent clinical services.

Innate Path is a Broomfield, Colorado psychedelic therapy clinic and training program specializing in ketamine and cannabis-assisted psychotherapy using a relational, somatic, and Buddhist-informed approach to trauma resolution through non-ordinary states. The center trains psychotherapists in its unique psycholytic model — integrating somatic, psychodynamic, parts work, and attachment modalities — while providing clinical ketamine and cannabis-assisted psychotherapy to patients.

Care delivery organization offering telehealth or hybrid psychedelic-adjacent clinical services.

The Institute of Psychedelic Therapy (IPT) is a UK-based professional training organization offering a comprehensive two-year psychedelic-assisted therapist training program combining weekly online lectures, in-person meetings, and 5-day experiential residential retreats each year. IPT emphasizes slow, relational skill cultivation, robust ethics, and integration of psychedelic work within long-term therapeutic frameworks, with graduates eligible for professional membership.

IDPAT is an Irish organization of doctors, psychotherapists, researchers, and other healthcare workers advocating for psychedelic-assisted therapy in Ireland. Its patient relevance is real, but it is mediated through clinician advocacy, health-system reform, and public reimbursement arguments. The record should therefore be recast as a multi-role stakeholder rather than a straightforward patient organization. Its public language centers on making psychedelic-assisted therapy publicly available and reimbursed, which is highly relevant to access policy and implementation planning.

SIMEPSI, the Italian Society for Psychedelic Medicine, is a nonprofit scientific society based in Italy and focused on psychedelic medicine. Its official materials describe it as a multidisciplinary community of doctors, therapists, researchers, and humanists working to advance research and informed discussion on psychedelic compounds and their therapeutic potential. It appears to operate nationally, with a primary focus on the Italian regulatory and clinical context. SIMEPSI presents itself as a field-building organization rather than a patient service provider. Its stated activities include promoting clinical and basic research, sharing knowledge among experts, supporting training and professional development, and collaborating with institutions on regulation and safe access to psychedelic treatments. It also frames part of its role around public education, risk awareness, and discussion of the social and cultural implications of psychedelic practices.

Care-delivery platform for ketamine-assisted psychotherapy enabling licensed therapists to deliver KAP through a coordinated technology and prescriber network model.

Care delivery organization offering telehealth or hybrid psychedelic-adjacent clinical services.

Care delivery organization offering telehealth or hybrid psychedelic-adjacent clinical services.

Care delivery organization providing specialty or outpatient psychedelic-adjacent clinical services.

Denver-based psychedelic education platform founded by Nicole Lilly, a somatic psychologist and healing arts practitioner with over 12 years of experience in entheogenic and psychedelic services, offering courses in the proprietary Luminous Methodology and Philosophy for embodied psycho-spiritual growth. The Luminous Guide specializes in self-guided sacred mushroom journeys, combining somatic psychology, body-centered practices, and sacred technologies for holistic healing and integration.

Maple Counseling Center is a low-fee nonprofit counseling center in Beverly Hills, California that co-sponsors continuing education courses on psychedelic-assisted psychotherapy for mental health professionals in partnership with the Lifespan Learning Institute. The center promotes evidence-based and emerging therapeutic modalities for the Southern California mental health community.

Microdosing for Healing is a platform founded by Kayse Gehret that provides coaching, guided microdosing immersions, community support, and professional facilitator training for using plant/earth medicines to support personal, physical, and spiritual healing. It runs courses, a podcast, and certification programs for practitioners and guides.

Ketamine therapy platform combining telehealth, digital treatment flow, and app-guided support for depression and related mental health conditions.

Founded in 2011, Mindspace Wellbeing is a Montreal-based psychology clinic that pioneered psychedelic-assisted therapy in Quebec, becoming the province's first provider of ketamine-assisted psychotherapy for treatment-resistant depression and launching Canada's first psychedelic harm reduction and integration training for clinicians. Acquired by Numinus Wellness in 2021, they continue offering evidence-based psychotherapy alongside ketamine and psilocybin programming.

The Norwegian Association for Psychedelic Science advances psychedelic science as a responsible, interdisciplinary, evidence-based field through knowledge dissemination, professional dialogue, and collaboration between research, clinical practice, and society.

Digital ketamine treatment platform offering app-enabled preparation, guided sessions, and integration support for mental health care.

Founded by Dr. Stephanie Van Hope, RN, DNP—a veteran of NYU's psilocybin cancer anxiety study—Nursing & Sacred Medicine offers the only extensive online course platform on psychedelic therapy designed specifically for nurses, blending sacred medicine traditions, current clinical science, and holistic nursing practice. Their self-paced and interactive courses aim to cultivate a psychedelic nursing community and prepare nurses at all practice levels.

Polaris Insight Center is a San Francisco Bay Area ketamine-assisted psychotherapy clinic and APA-approved training center co-founded by MAPS-trained therapist Veronika Gold LMFT, offering a comprehensive KAP training program of online didactic modules, in-person experiential retreats, consultation groups, and a 1–2 year practitioner certificate. The center provides KAP patient care while training clinicians across foundational, advanced, and special topics series in ketamine and psychedelic-assisted therapy.

Portland Psychotherapy is a Portland, Oregon clinic, research, and training center that integrates psychedelic science into evidence-based clinical practice, conducting clinical trials of MDMA-assisted therapy for social anxiety disorder and offering psychedelic integration services. Their distinctive model funds peer-reviewed research through clinical revenue, resulting in exceptionally well-trained therapists in psychedelic-assisted care.

The Psychedelic Medicine Association (PMA) is a professional association that educates and connects healthcare practitioners about the therapeutic use of psychedelic medicines. It also develops clinical practice guidelines, training accreditation, and related infrastructure to support safe integration of psychedelic therapies into mainstream healthcare.

Psychedelic Society Croatia promotes research, education, and ethical application of psychedelics in mental health.

Psychedelic Support is an online education and therapeutic platform offering accredited continuing education, online courses, and a vetted directory of licensed healthcare providers and community groups focused on psychedelic integration, harm reduction, and clinical referrals. It was founded in March 2018 to advance legal psychedelic-assisted therapies and professional training. ([psychedelic.support](https://psychedelic.support/our-story/))

Founded in 2019, Resilience Behavioral Health Solutions is a Tucson, Arizona clinic specializing in intramuscular ketamine-assisted psychotherapy (KAP) for treatment-resistant depression, PTSD, and trauma, using approaches modeled on MDMA and psilocybin clinical trial protocols. They also offer AANP-accredited 4-day KAP training programs for licensed clinicians and mental health providers.

Care delivery organization providing specialty or outpatient psychedelic-adjacent clinical services.

Regional psychiatric college issuing clinical memoranda and implementation guidance on psychedelic-assisted therapy, including MDMA and psilocybin use in regulated psychiatric contexts.

Dutch specialist GGZ practice in Nibbixwoud offering ketamine-assisted psychotherapy for treatment-resistant depression within a psychotherapeutic treatment pathway under psychiatrist and anesthesiologist responsibility.

SoundMind Institute is a Philadelphia-based psychedelic-assisted psychotherapy training, treatment, and research organization founded by Dr. Hannah McLane, offering a comprehensive year-long Psychedelic Practitioner Training Program and ketamine-assisted psychotherapy treatment. Integrating Indigenous healing traditions with clinical evidence, its nonprofit arm has provided over $280,000 in scholarships to BIPOC and underrepresented psychedelic providers.

SEMPsi, or the Sociedad Española de Medicina Psicodélica, is a Spanish nonprofit society made up of clinical professionals and mental health researchers. It operates primarily in Spain and appears to serve clinicians, researchers, and other health professionals interested in psychedelic medicine. The group describes its work as promoting therapeutic use and research on psychedelics in an ethical, culturally respectful, evidence-based context. SEMPsi's role is mainly public education, professional formation, and field-building rather than direct patient service delivery. Its manifesto says it produces scientific outreach, training, ethical codes, treatment protocols, and good-practice guidance, and it also aims to advise public and private institutions on clinical use and future legal implementation. Documented current activity includes journal clubs, a university course on psychedelic-assisted psychotherapies, and a parliamentary event in Spain on psychedelic-assisted therapies, as well as coordination with the citizen initiative PsychedeliCare.

Practitioner-led care organization listed in curated practitioner ecosystem seed data.

The Swiss Medical Association for Psychedelic Therapy (SÄPT) is a Switzerland-based professional medical society founded in 1986, with a German-speaking, interdisciplinary membership that includes psychiatry, psychotherapy, neurology, palliative care, and general medicine. It operates nationally in Switzerland and reports roughly 260 members. Its core activities include improving clinical quality in psychedelic-assisted therapy, supporting professional exchange, and providing theoretical and practical training. SÄPT plays a field-building role in Switzerland’s psychedelic medicine ecosystem by promoting research, developing ethical and treatment standards, and supporting practitioners working under Swiss exceptional authorizations. The organization also engages in policy and health-system advocacy on behalf of its members and participates in the IG PAT network, which issues treatment recommendations for psychedelic-assisted therapy. Current documented initiatives include an education calendar, an academy/training offer, research pages, institutional working groups, and an ombud/service function for people seeking information about psychedelic therapy.

Founded in 2019 by Dr. Rafael Gonzalez-Vizoso and Scott Ross, Telos is a Mountlake Terrace, Washington practice offering ketamine-assisted psychotherapy through a collaborative model that enables licensed practitioners to integrate psychedelic-assisted therapy into their practices. They also offer training in core competencies of ketamine-assisted therapy for mental health providers.

Care delivery organization providing specialty or outpatient psychedelic-adjacent clinical services.

A Canadian nonprofit healthcare organization based in British Columbia offering evidence-informed, community-based psychedelic-assisted group therapy programs. Canada's first organization to receive Health Canada Special Access Program approval for psilocybin group therapy, Roots to Thrive serves patients with PTSD, treatment-resistant depression, and end-of-life distress through Indigenous-informed, trauma-centered care.

Care delivery organization offering telehealth or hybrid psychedelic-adjacent clinical services.